Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Romero Falcon, A. Montes Worboys, J. L. Lopez-Campos Bodineau, A. Casas Fernandez de Tejerina, F. Rodriguez Panadero (Sevilla, Spain). Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast carcinoma. Eur Respir J 2008; 32: Suppl. 52, 671

Member's Comments

No comment yet.

Related content which might interest you: Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines Year: 2009 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Therapeutic outcome and prognostic factors in patients with pleural mesothelioma Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005 Survival and clinico-pathologic prognostic factors in surgically resected non-small cell lung carcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 751s Year: 2006 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM) Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Biochemical and cytological features of metastatic pleural effusions in breast cancer Source: Eur Respir J 2007; 30: Suppl. 51, 671s Year: 2007 Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2003; 22: Suppl. 45, 509s Year: 2003 Ultra-late pleural metastasis of breast cancer: are they so rare? Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 Prognostic factors and surgical resection of pulmonary metastases from colorectal cancer Source: International Congress 2019 – General thoracic surgery Year: 2019 The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Is comorbidity a good prognostic factor for malignant pleural mesothelioma? Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Factors affecting the prognosis of nonsmall cell lung cancer with chest wall-parietal pleural invasion (T3) following resection Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Clinicopathological prognostic factors in operated for lung cancer and brain metastasis patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 The analysis of clinicopathological characteristics and prognosis of malignant pleural mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003